Novavax | NVAX - Pre Tax Profit

Stock Price
9.87
Daily Change
-0.03 -0.25%
Monthly
19.58%
Yearly
25.35%
Q1 Forecast
9.83

Novavax reported $-122.33M in Pre-Tax Profit for its fiscal quarter ending in September of 2024.





Pre Tax Profit Change Date
Adma Biologics USD 47.52M 7.42M Sep/2025
Agenus USD -274.14M 80.46M Sep/2025
AstraZeneca USD 3.24B 117M Sep/2025
BioCryst Pharmaceuticals USD -86.95M 73.5M Dec/2024
Cassava Sciences USD -10.81M 33.41M Sep/2025
Geron USD -31.14M 12.72M Dec/2025
GlaxoSmithKline GBP 1.23B 1.23B Dec/2025
MannKind USD -20.93M 28.71M Dec/2025
Merck USD 6.74B 22M Sep/2025
Minerva Neurosciences USD 22.51M 30.74M Sep/2024
Moderna USD -187M 631M Sep/2025
Novartis USD 5.17B 637M Sep/2025
Novavax USD -122.33M 286.92M Sep/2024
Pfizer USD 3.33B 290M Sep/2025
Sanofi EUR -1.16B 5.5B Dec/2025
Sarepta Therapeutics USD -407.67M 213.63M Dec/2025
TG Therapeutics USD 45.09M 19.18M Dec/2025